{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T01:21:55Z","timestamp":1769304115053,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":2312,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1111\/j.1469-0691.2008.02035.x","type":"journal-article","created":{"date-parts":[[2008,7,22]],"date-time":"2008-07-22T17:24:27Z","timestamp":1216747467000},"page":"766-777","source":"Crossref","is-referenced-by-count":28,"title":["Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis"],"prefix":"10.1016","volume":"14","author":[{"given":"S.","family":"Lemaire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kosowska-Shick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Julian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Tulkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Van Bambeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.C.","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2008.02035.x_bib1","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI18535","article-title":"Antimicrobial resistance: the example of Staphylococcus aureus","volume":"111","author":"Lowy","year":"2003","journal-title":"J Clin Invest"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2008.02035.x_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-0691.2006.01402.x","article-title":"MRSA\u2014the tip of the iceberg","volume":"12","author":"Appelbaum","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2008.02035.x_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1469-0691.2006.01344.x","article-title":"The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus","volume":"12","author":"Appelbaum","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib4","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1128\/JCM.01262-06","article-title":"Prevalence and characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center","volume":"45","author":"Maor","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ijantimicag.2007.07.011","article-title":"Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)","volume":"30","author":"Appelbaum","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/AAC.47.2.568-576.2003","article-title":"Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin","volume":"47","author":"Reipert","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/AAC.50.2.428-438.2006","article-title":"Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib8","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1128\/AAC.47.6.2036-2039.2003","article-title":"Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin-intermediate resistance","volume":"47","author":"Boyle-Vavra","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib9","first-page":"249","article-title":"Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis","volume":"44","author":"Plouin-Gaudon","year":"2006","journal-title":"Rhinology"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/432735","article-title":"Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis","volume":"192","author":"Clement","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1302\/0301-620X.85B6.13509","article-title":"Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis","volume":"85","author":"Ellington","year":"2003","journal-title":"J Bone Joint Surg Br"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1160\/TH05-04-0235","article-title":"Mechanism and consequences of invasion of endothelial cells by Staphylococcus aureus","volume":"94","author":"Sinha","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib13","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1046\/j.1365-2133.2002.04752.x","article-title":"Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin-independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death","volume":"146","author":"Mempel","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jac\/dkh076","article-title":"Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells","volume":"53","author":"Krut","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijantimicag.2005.10.008","article-title":"Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains","volume":"27","author":"Bhateja","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib16","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1128\/jb.179.8.2557-2566.1997","article-title":"Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus","volume":"179","author":"Sieradzki","year":"1997","journal-title":"J Bacteriol"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib17","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1128\/JB.185.24.7103-7110.2003","article-title":"Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus","volume":"185","author":"Sieradzki","year":"2003","journal-title":"J Bacteriol"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib18","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/AAC.00559-07","article-title":"Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis","volume":"51","author":"Julian","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/jac\/dki094","article-title":"Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus","volume":"55","author":"Lemaire","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/AAC.50.3.841-851.2006","article-title":"Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages","volume":"50","author":"Barcia-Macay","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1128\/JCM.41.1.456-459.2003","article-title":"Prevalence of agr specificity groups among Staphylococcus aureus strains colonizing children and their guardians","volume":"41","author":"Shopsin","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib22","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/JCM.43.10.5026-5033.2005","article-title":"Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Zhang","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib23","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1128\/AAC.01192-06","article-title":"Role of acidic pH in the susceptibility of intraphagocytic methicillin-resistant Staphylococcus aureus strains to meropenem and cloxacillin","volume":"51","author":"Lemaire","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib24","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1128\/AAC.00090-07","article-title":"Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and Madin-Darby canine kidney cells","volume":"51","author":"Lemaire","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib26","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/JB.156.3.1099-1106.1983","article-title":"Rates of peptidoglycan turnover and cell growth of Bacillus subtilis are correlated","volume":"156","author":"Cheung","year":"1983","journal-title":"J Bacteriol"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib27","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/AAC.47.7.2283-2292.2003","article-title":"Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages","volume":"47","author":"Seral","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib28","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/AAC.40.5.1225","article-title":"Effect of recombinant human gamma interferon on intracellular activities of antibiotics against Listeria monocytogenes in the human macrophage cell line THP-1","volume":"40","author":"Scorneaux","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib29","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1128\/AAC.49.10.4210-4219.2005","article-title":"Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin","volume":"49","author":"Bogdanovich","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl A","key":"10.1111\/j.1469-0691.2008.02035.x_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/30.suppl_A.67","article-title":"Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide\u2013lincosamide\u2013streptogramin antibiotics","volume":"30","author":"Leclercq","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijantimicag.2004.06.016","article-title":"Bactericidal activity of quinupristin\u2013dalfopristin against strains of Staphylococcus aureus with the MLS(B) phenotype of resistance according to the erm gene type","volume":"24","author":"Clarebout","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib32","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1086\/421092","article-title":"Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy","volume":"38","author":"Moise-Broder","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/dki059","article-title":"Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages","volume":"55","author":"Seral","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib34","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/jac\/dkl424","article-title":"Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus","volume":"58","author":"Barcia-Macay","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib36","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1128\/AAC.00431-07","article-title":"Fluorescence ratio imaging microscopy shows decreased access of vancomycin to cell wall synthetic sites in vancomycin-resistant Staphylococcus aureus","volume":"51","author":"Pereira","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib37","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1086\/368128","article-title":"Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?","volume":"187","author":"Sakoulas","year":"2003","journal-title":"J Infect Dis"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2008.02035.x_bib38","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1086\/491710","article-title":"Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal\/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains","volume":"42","author":"Jones","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JCM.44.2.595-597.2006","article-title":"Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis","volume":"44","author":"Marty","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib40","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijantimicag.2006.05.030","article-title":"Mechanisms of daptomycin resistance in Staphylococcus aureus","volume":"28","author":"Kaatz","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/AAC.00719-07","article-title":"Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding","volume":"52","author":"Jones","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0966-842X(00)01803-5","article-title":"Is Staphylococcus aureus an intracellular pathogen?","volume":"8","author":"Lowy","year":"2000","journal-title":"Trends Microbiol"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib43","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1128\/AAC.00973-06","article-title":"Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and\/or rifampin in human monocytes and in broth against Staphylococcus aureus","volume":"51","author":"Baltch","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2008.02035.x_bib44","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0924-8579(98)00073-9","article-title":"Fusidic acid in vitro activity","volume":"12","author":"Collignon","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ijantimicag.2007.10.026","article-title":"Staphylococcus aureus small colony variants: a challenge to microbiologists and clinicians","volume":"31","author":"von Eiff","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tips.2007.12.004","article-title":"The bacterial envelope as a target for novel anti-MRSA antibiotics","volume":"25","author":"Van Bambeke","year":"2008","journal-title":"Trends Pharmacol Sci"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2008.02035.x_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2165\/00003495-199600511-00006","article-title":"Mechanism of action of streptogramins and macrolides","volume":"51","author":"Vannuffel","year":"1996","journal-title":"Drugs"},{"issue":"suppl A","key":"10.1111\/j.1469-0691.2008.02035.x_bib48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/jac\/30.suppl_A.107","article-title":"Cellular uptake and intracellular bactericidal activity of RP 59500 in murine macrophages","volume":"30","author":"Desnottes","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib49","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/AAC.48.8.2853-2860.2004","article-title":"Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages","volume":"48","author":"Van Bambeke","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0006-2952(78)90370-2","article-title":"The uptake and intracellular accumulation of aminoglycoside antibiotics in lysosomes of cultured rat fibroblasts","volume":"27","author":"Tulkens","year":"1978","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib51","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1128\/AAC.45.11.2977-2986.2001","article-title":"Use of aminoglycosides in treatment of infections due to intracellular bacteria","volume":"45","author":"Maurin","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib52","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus","volume":"44","author":"Tenover","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.02035.x_bib53","series-title":"Methods for determining bactericidal activity of antimicrobial agents. Approved guideline","author":"National Committee for Clinical Laboratory Standards","year":"1998"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14621236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14621236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T08:43:31Z","timestamp":1684485811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14621236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S1198743X14621236"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2008.02035.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}